FDA Reviews New Data on Anemia Drugs:
Heightened leukemia risk
New York Times
Expert Summary
Here's one more reason for the FDA to review new data on anemia drugs: A Mayo Clinic study showed an increased risk of developing leukemia in patients with bone marrow disease.
Irina Ostrovsky-Day
Expert Scorecard
Overall Expert Score
Community Reviews
Overall Community Rating:
(0 reviews)
Add your rating:
click to select